Cargando…
Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections: A pilot study
BACKGROUND & OBJECTIVES: There is little information concerning intravenously (i.v.) administered colistin in patients with multidrug-resistant (MDR) Gram-negative infections. Thus, this pilot prospective study was undertaken to characterize efficacy and pharmacokinetics of colistin in patients...
Autores principales: | Gautam, Vikas, Shafiq, Nusrat, Mouton, Johan W., Malhotra, Sameer, Kaur, Satinder, Ray, Pallab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057249/ https://www.ncbi.nlm.nih.gov/pubmed/29998877 http://dx.doi.org/10.4103/ijmr.IJMR_1464_16 |
Ejemplares similares
-
Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates
por: Shafiq, Nusrat, et al.
Publicado: (2017) -
Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020) -
Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013) -
Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023) -
Colistin Treatment for Multidrug-Resistant Gram-Negative Infections in Children: Caution Required for Nephrotoxicity
por: Ustundag, Gulnihan, et al.
Publicado: (2022)